enrofloxacin has been researched along with 1,10-phenanthroline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Efthimiadou, EK; Karaliota, A; Katsarou, ME; Psomas, G; Vourloumis, D | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Kessissoglou, DP; Kljun, J; Lafazanis, K; Pantazaki, AA; Psomas, G; Tarushi, A; Turel, I | 1 |
| Akrivou, M; Andreadou, EG; Pantazaki, AA; Psomas, G; Psycharis, V; Raptopoulou, CP; Zampakou, M | 1 |
4 other study(ies) available for enrofloxacin and 1,10-phenanthroline
| Article | Year |
|---|---|
Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Copper; Deoxyribonucleases; DNA, Superhelical; Escherichia coli; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Microbial Sensitivity Tests; Necrosis; Norfloxacin; Organometallic Compounds; Phenanthrolines; Pseudomonas aeruginosa; Staphylococcus aureus | 2008 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
First- and second-generation quinolone antibacterial drugs interacting with zinc(II): structure and biological perspectives.
Topics: 2,2'-Dipyridyl; Animals; Anti-Bacterial Agents; Binding Sites; Binding, Competitive; Cattle; Coordination Complexes; Crystallography, X-Ray; DNA; Enrofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intercalating Agents; Kinetics; Microbial Sensitivity Tests; Models, Chemical; Oxolinic Acid; Phenanthrolines; Serum Albumin; Zinc | 2013 |
Structure, antimicrobial activity, DNA- and albumin-binding of manganese(II) complexes with the quinolone antimicrobial agents oxolinic acid and enrofloxacin.
Topics: 2,2'-Dipyridyl; Animals; Anti-Bacterial Agents; Binding Sites; Binding, Competitive; Cattle; Coordination Complexes; Crystallography, X-Ray; DNA; Enrofloxacin; Ethidium; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intercalating Agents; Kinetics; Manganese; Microbial Sensitivity Tests; Models, Molecular; Oxolinic Acid; Phenanthrolines; Serum Albumin | 2013 |